Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

ClinicalTrials.gov ID: NCT00005580

Public ClinicalTrials.gov record NCT00005580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Study of Bryostatin 1 (NSC 339555) and Fludarabine in Patients With Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin's Lymphoma

Study identification

NCT ID: NCT00005580
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Virginia Commonwealth University; Other
Enrollment: 54 participants

Conditions and interventions

Conditions

Interventions

bryostatin 1 Drug
fludarabine phosphate Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 1998
Primary completion: Jul 31, 2006
Completion: Jul 31, 2006
Last update posted: Feb 23, 2010

1998 – 2006

United States locations

U.S. sites: 3
U.S. states: 3
U.S. cities: 3

Facility	City	State	ZIP	Site status
New York Presbyterian Hospital - Cornell Campus	New York	New York	10021	—
Fox Chase Cancer Center	Philadelphia	Pennsylvania	19111	—
Massey Cancer Center	Richmond	Virginia	23298-0037	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00005580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 23, 2010 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00005580 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →